AstraZeneca Plc, fighting off a $106 billion takeover approach from Pfizer Inc, painted a bullish picture of its new drug pipeline on Tuesday and forecast drug sales would exceed $45 billion by 2023. Britain's second biggest drugmaker recorded sales of $25.7 billion in 2013.
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. Shares of AZN fell by 1.42% or $-1.15/share to $79.87. In the past year, the shares have traded as low as $46.87 and as high as $82.68. On average, 3546180 shares of AZN exchange hands on a given day and today's volume is recorded at 5803759.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE fell by 2.57% or $-0.79/share to $29.96. In the past year, the shares have traded as low as $27.12 and as high as $32.96. On average, 28994300 shares of PFE exchange hands on a given day and today's volume is recorded at 54909064.
Source
